311 related articles for article (PubMed ID: 37359189)
41. TCF7L2 activated HOXA-AS2 decreased the glucocorticoid sensitivity in acute lymphoblastic leukemia through regulating HOXA3/EGFR/Ras/Raf/MEK/ERK pathway.
Zhao Q; Zhao S; Li J; Zhang H; Qian C; Wang H; Liu J; Zhao Y
Biomed Pharmacother; 2019 Jan; 109():1640-1649. PubMed ID: 30551418
[TBL] [Abstract][Full Text] [Related]
42. LRH-1/NR5A2 interacts with the glucocorticoid receptor to regulate glucocorticoid resistance.
Michalek S; Goj T; Plazzo AP; Marovca B; Bornhauser B; Brunner T
EMBO Rep; 2022 Sep; 23(9):e54195. PubMed ID: 35801407
[TBL] [Abstract][Full Text] [Related]
43. PI3K inhibition synergizes with glucocorticoids but antagonizes with methotrexate in T-cell acute lymphoblastic leukemia.
Silveira AB; Laranjeira AB; Rodrigues GO; Leal PC; Cardoso BA; Barata JT; Yunes RA; Zanchin NI; Brandalise SR; Yunes JA
Oncotarget; 2015 May; 6(15):13105-18. PubMed ID: 25869207
[TBL] [Abstract][Full Text] [Related]
44. Genetic and Epigenetic Targeting Therapy for Pediatric Acute Lymphoblastic Leukemia.
Xu H; Yu H; Jin R; Wu X; Chen H
Cells; 2021 Nov; 10(12):. PubMed ID: 34943855
[TBL] [Abstract][Full Text] [Related]
45. Gamma-secretase inhibitors reverse glucocorticoid resistance in T cell acute lymphoblastic leukemia.
Real PJ; Tosello V; Palomero T; Castillo M; Hernando E; de Stanchina E; Sulis ML; Barnes K; Sawai C; Homminga I; Meijerink J; Aifantis I; Basso G; Cordon-Cardo C; Ai W; Ferrando A
Nat Med; 2009 Jan; 15(1):50-8. PubMed ID: 19098907
[TBL] [Abstract][Full Text] [Related]
46. Latest perspectives on glucocorticoid-induced apoptosis and resistance in lymphoid malignancies.
Clarisse D; Offner F; De Bosscher K
Biochim Biophys Acta Rev Cancer; 2020 Dec; 1874(2):188430. PubMed ID: 32950642
[TBL] [Abstract][Full Text] [Related]
47. Rhinovirus infection causes steroid resistance in airway epithelium through nuclear factor κB and c-Jun N-terminal kinase activation.
Papi A; Contoli M; Adcock IM; Bellettato C; Padovani A; Casolari P; Stanciu LA; Barnes PJ; Johnston SL; Ito K; Caramori G
J Allergy Clin Immunol; 2013 Nov; 132(5):1075-1085.e6. PubMed ID: 23871663
[TBL] [Abstract][Full Text] [Related]
48. Beyond Corticoresistance, A Paradoxical Corticosensitivity Induced by Corticosteroid Therapy in Pediatric Acute Lymphoblastic Leukemias.
Angot L; Schneider P; Vannier JP; Abdoul-Azize S
Cancers (Basel); 2023 May; 15(10):. PubMed ID: 37345151
[TBL] [Abstract][Full Text] [Related]
49. Preclinical analysis of the γ-secretase inhibitor PF-03084014 in combination with glucocorticoids in T-cell acute lymphoblastic leukemia.
Samon JB; Castillo-Martin M; Hadler M; Ambesi-Impiobato A; Paietta E; Racevskis J; Wiernik PH; Rowe JM; Jakubczak J; Randolph S; Cordon-Cardo C; Ferrando AA
Mol Cancer Ther; 2012 Jul; 11(7):1565-75. PubMed ID: 22504949
[TBL] [Abstract][Full Text] [Related]
50. Src kinase-induced phosphorylation of annexin A2 mediates glucocorticoid resistance in MLL-rearranged infant acute lymphoblastic leukemia.
Spijkers-Hagelstein JA; Mimoso Pinhanços S; Schneider P; Pieters R; Stam RW
Leukemia; 2013 Apr; 27(5):1063-71. PubMed ID: 23334362
[TBL] [Abstract][Full Text] [Related]
51. HDAC inhibitors induce apoptosis in glucocorticoid-resistant acute lymphatic leukemia cells despite a switch from the extrinsic to the intrinsic death pathway.
Tsapis M; Lieb M; Manzo F; Shankaranarayanan P; Herbrecht R; Lutz P; Gronemeyer H
Int J Biochem Cell Biol; 2007; 39(7-8):1500-9. PubMed ID: 17499001
[TBL] [Abstract][Full Text] [Related]
52. Bioenergetic modulation overcomes glucocorticoid resistance in T-lineage acute lymphoblastic leukaemia.
Samuels AL; Heng JY; Beesley AH; Kees UR
Br J Haematol; 2014 Apr; 165(1):57-66. PubMed ID: 24456076
[TBL] [Abstract][Full Text] [Related]
53. DT7 peptide-modified lecithin nanoparticles co-loaded with γ-secretase inhibitor and dexamethasone efficiently inhibit T-cell acute lymphoblastic leukemia and reduce gastrointestinal toxicity.
Zhou Y; Guan L; Li W; Jia R; Jia L; Zhang Y; Wen X; Meng S; Ma D; Zhang N; Ji M; Liu Y; Ji C
Cancer Lett; 2022 May; 533():215608. PubMed ID: 35240234
[TBL] [Abstract][Full Text] [Related]
54. Elevated S100A8/S100A9 expression causes glucocorticoid resistance in MLL-rearranged infant acute lymphoblastic leukemia.
Spijkers-Hagelstein JA; Schneider P; Hulleman E; de Boer J; Williams O; Pieters R; Stam RW
Leukemia; 2012 Jun; 26(6):1255-65. PubMed ID: 22282267
[TBL] [Abstract][Full Text] [Related]
55. Opposing regulation of BIM and BCL2 controls glucocorticoid-induced apoptosis of pediatric acute lymphoblastic leukemia cells.
Jing D; Bhadri VA; Beck D; Thoms JA; Yakob NA; Wong JW; Knezevic K; Pimanda JE; Lock RB
Blood; 2015 Jan; 125(2):273-83. PubMed ID: 25336632
[TBL] [Abstract][Full Text] [Related]
56. Molecular mechanisms and therapeutic implications of tetrandrine and cepharanthine in T cell acute lymphoblastic leukemia and autoimmune diseases.
Xu W; Chen S; Wang X; Tanaka S; Onda K; Sugiyama K; Yamada H; Hirano T
Pharmacol Ther; 2021 Jan; 217():107659. PubMed ID: 32800789
[TBL] [Abstract][Full Text] [Related]
57. JAK3 mutations and mitochondrial apoptosis resistance in T-cell acute lymphoblastic leukemia.
Bodaar K; Yamagata N; Barthe A; Landrigan J; Chonghaile TN; Burns M; Stevenson KE; Devidas M; Loh ML; Hunger SP; Wood B; Silverman LB; Teachey DT; Meijerink JP; Letai A; Gutierrez A
Leukemia; 2022 Jun; 36(6):1499-1507. PubMed ID: 35411095
[TBL] [Abstract][Full Text] [Related]
58. Role of Autophagy and Apoptosis in Acute Lymphoblastic Leukemia.
Huang FL; Yu SJ; Li CL
Cancer Control; 2021; 28():10732748211019138. PubMed ID: 34169775
[TBL] [Abstract][Full Text] [Related]
59. Glucocorticoid sensitisation in Mixed Lineage Leukaemia-rearranged acute lymphoblastic leukaemia by the pan-BCL-2 family inhibitors gossypol and AT-101.
Spijkers-Hagelstein JA; Schneider P; Pinhanços SM; Garrido Castro P; Pieters R; Stam RW
Eur J Cancer; 2014 Jun; 50(9):1665-74. PubMed ID: 24703900
[TBL] [Abstract][Full Text] [Related]
60. Huai Qi Huang Potentiates Dexamethasone-Mediated Lethality in Acute Lymphoblastic Leukemia Cells by Upregulating Glucocorticoid Receptor α.
Xu W; Wang Z; Li K; Jin R
Med Sci Monit; 2020 Feb; 26():e921649. PubMed ID: 32065117
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]